tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

DRTS Stock Latest News

Alpha Tau’s Alpha DaRT Gains FDA Study Approval
Company AnnouncementsAlpha Tau’s Alpha DaRT Gains FDA Study Approval
18h ago
6K
DRTS
Alpha Tau Announces FDA Approval of IDE to Initiate Multi-Center Investigator-Initiated Study of Alpha DaRT® in Immunocompromised Patients with Recurrent cSCC
PremiumPress Releases
Alpha Tau Announces FDA Approval of IDE to Initiate Multi-Center Investigator-Initiated Study of Alpha DaRT® in Immunocompromised Patients with Recurrent cSCC
18h ago
DRTS
Alpha Tau announces FDA approval of IDE to initiate study of Alpha DaRT
PremiumThe Fly
Alpha Tau announces FDA approval of IDE to initiate study of Alpha DaRT
18h ago
DRTS
Alpha Tau Medical to Showcase Cancer Therapy at Global Conferences
PremiumCompany Announcements
Alpha Tau Medical to Showcase Cancer Therapy at Global Conferences
30d ago
6K
DRTS
Alpha Tau to Participate in the H.C. Wainwright 26th Annual Global Investment Conference, the Sidoti Small-Cap Virtual Investor Conference, the Redburn Atlantic and Rothschild & Co 2024 Radiopharma Conference, and the Lytham Partners Fall 2024 Investor Conference
PremiumPress Releases
Alpha Tau to Participate in the H.C. Wainwright 26th Annual Global Investment Conference, the Sidoti Small-Cap Virtual Investor Conference, the Redburn Atlantic and Rothschild & Co 2024 Radiopharma Conference, and the Lytham Partners Fall 2024 Investor Conference
30d ago
DRTS
Alpha Tau resumed with a Buy at Citi
PremiumThe FlyAlpha Tau resumed with a Buy at Citi
1M ago
DRTS
Alpha Tau Medical Reports Mid-Year Financials
Premium
Company Announcements
Alpha Tau Medical Reports Mid-Year Financials
1M ago
6K
DRTS
Alpha Tau Medical Shows Strong Clinical Results
Premium
Company Announcements
Alpha Tau Medical Shows Strong Clinical Results
1M ago
6K
DRTS
Alpha Tau reports1H EPS (22c) vs (24c) in 1H23
PremiumThe Fly
Alpha Tau reports1H EPS (22c) vs (24c) in 1H23
1M ago
DRTS
Alpha Tau Medical Announces Second Quarter 2024 Financial Results and Provides Corporate Update
PremiumPress Releases
Alpha Tau Medical Announces Second Quarter 2024 Financial Results and Provides Corporate Update
1M ago
DRTS
Alpha Tau’s Alpha DaRT Shows Promise in Cancer Therapy
PremiumCompany Announcements
Alpha Tau’s Alpha DaRT Shows Promise in Cancer Therapy
3M ago
6K
DRTS
Alpha Tau publishes long-term safety, efficacy data in superficial cancers
PremiumThe Fly
Alpha Tau publishes long-term safety, efficacy data in superficial cancers
3M ago
DRTS
Alpha Tau Announces Publication in Cancers Journal of Long-Term Safety and Efficacy Data in Multiple Hard-to-Treat Superficial Cancers
PremiumPress ReleasesAlpha Tau Announces Publication in Cancers Journal of Long-Term Safety and Efficacy Data in Multiple Hard-to-Treat Superficial Cancers
3M ago
DRTS
option delistings on June 3rd
Premium
The Fly
option delistings on June 3rd
4M ago
JG
AKA
Alpha Tau Medical to Spotlight Alpha DaRT at Healthcare Conference
Premium
Company Announcements
Alpha Tau Medical to Spotlight Alpha DaRT at Healthcare Conference
4M ago
6K
DRTS
Alpha Tau to Present at the Jefferies Global Healthcare Conference
PremiumPress Releases
Alpha Tau to Present at the Jefferies Global Healthcare Conference
4M ago
DRTS
Alpha Tau Medical’s Q1 2024 Financial and Clinical Progress
PremiumCompany Announcements
Alpha Tau Medical’s Q1 2024 Financial and Clinical Progress
4M ago
6K
DRTS
Alpha Tau reports Q1 EPS (11c), consensus (13c)
PremiumThe Fly
Alpha Tau reports Q1 EPS (11c), consensus (13c)
4M ago
DRTS
Alpha Tau Medical Announces First Quarter 2024 Financial Results and Provides Corporate Update
PremiumPress Releases
Alpha Tau Medical Announces First Quarter 2024 Financial Results and Provides Corporate Update
4M ago
DRTS
DRTS Earnings this Week: How Will it Perform?
PremiumPre-EarningsDRTS Earnings this Week: How Will it Perform?
4M ago
DRTS
Alpha Tau announces Alpha DaRT treatment of first patient with liver cancer
Premium
The Fly
Alpha Tau announces Alpha DaRT treatment of first patient with liver cancer
4M ago
DRTS
Alpha Tau Announces Alpha DaRT Treatment of First Patient with Liver Metastases of Colorectal Cancer
Premium
Press Releases
Alpha Tau Announces Alpha DaRT Treatment of First Patient with Liver Metastases of Colorectal Cancer
4M ago
DRTS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >